February 2024 — Pharma News Archive

Every regulatory action (73), Phase 3 readout (0), and patent expiry (2) tracked in February 2024. Sourced from Drugs@FDA, EMA EPAR, ClinicalTrials.gov, USPTO Orange Book.

73 regulatory actions 0 Phase 3 readouts 2 patent expiries

Regulatory actions (73)

Phase 3 trial readouts (0)

No Phase 3 readouts tracked in this month.

Patent expiries (2)

Subscribe to ongoing alerts

This page is a permanent monthly archive. For ongoing alerts as new events happen:

See also